Evidence map›Paper›PMID 39656203›Full record

ArticleThe Journal of experimental medicine2025

CCDC134 controls TLR biogenesis through the ER chaperone Gp96.

Léa Bernaleau, Michaela Drobek, Fenja Blank, Philipp Walch, Maeva Delacrétaz, Ales Drobek, Marta Monguió-Tortajada, Petr Broz, Olivia Majer, Manuele Rebsamen

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. ER-resident CCDC134 safeguards TLR4 maturation by maintaining gp96 stability.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Léa BernaleauDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0009-0006-5892-0151
Michaela DrobekDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0000-0002-8972-4915
Fenja BlankMax Planck Institute for Infection Biology , Berlin, Germany.ORCID 0009-0004-4819-0963
Philipp WalchDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0000-0002-7978-5685
Maeva DelacrétazDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0009-0003-4154-5277
Ales DrobekDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0000-0003-1066-9413
Marta Monguió-TortajadaDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0000-0003-2125-0810
Petr BrozDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0000-0002-2334-7790
Olivia MajerMax Planck Institute for Infection Biology , Berlin, Germany.ORCID 0000-0001-9467-4898
Manuele RebsamenDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0000-0001-6172-4211

Funding

European Molecular Biology Organization ALTF-566-2022Fondation Pierre Mercier pour la scienceSwiss National Science Foundation 310030_200709
6 · The paper itself

Abstract

Toll-like receptors (TLRs) are central to initiate immune responses against invading pathogens. To ensure host defense while avoiding aberrant activation leading to pathogenic inflammation and autoimmune diseases, TLRs are tightly controlled by multilevel regulatory mechanisms. Through a loss-of-function genetic screen in a reporter cell line engineered to undergo cell death upon TLR7-induced IRF5 activation, we identified here CCDC134 as an essential factor for TLR responses. CCDC134 deficiency impaired endolysosomal TLR-induced NF-κB, MAPK, and IRF5 activation, as well as downstream production of proinflammatory cytokines and type I interferons. We further demonstrated that CCDC134 is an endoplasmic reticulum (ER)-resident interactor of Gp96 (HSP90B1/Grp94), an ER chaperone essential for folding and trafficking of plasma membrane and endolysosomal TLRs. CCDC134 controlled Gp96 stability as its loss led to Gp96 hyperglycosylation and ER-associated protein degradation (ERAD)-mediated clearance. Accordingly, CCDC134 deficiency impaired the folding, maturation, and trafficking of TLRs, resulting in blunted inflammatory responses upon stimulation. Altogether, this study reveals CCDC134 as a central regulator of the chaperone Gp96, thereby controlling TLR biogenesis and responses.

Indexed as

Endoplasmic ReticulumMembrane GlycoproteinsAnimalsEndoplasmic Reticulum-Associated DegradationHEK293 CellsHumansInflammationLysosomesMiceMolecular ChaperonesNF-kappa BSignal TransductionToll-Like ReceptorsendoplasminMembrane GlycoproteinsMolecular ChaperonesNF-kappa BToll-Like Receptors

Identifiers

PMID39656203
PMCPMC11629888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.